Despite a decline in net sales, Genomma Lab Internacional SAB de CV (GNMLF) focuses on market share recovery and growth in Latin America, while addressing challenges in Mexico and the US.

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the first quarter 2026. All figures included herein are stated in nominal Mexican ...

HOUSTON--(BUSINESS WIRE)--As consumers continue to adapt their behaviors due to the COVID-19 pandemic, offering quality and known products that can help them with their day-to-day life in the “new ...

Net sales: Increased +0.5%, or +5.5% excluding Argentina, impacted by an -18.3% Argentine peso depreciation and a weak beverage season in Mexico, partially offset by robust growth in the US, Brazil, ...

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"), today announced its results for the ...

Genomma Lab Internacional, S.A.B. de C.V. is one of the leading pharmaceutical and personal care products companies in Mexico with an increasing international presence. Genomma Lab develops, sells and ...

Agreement Combines Procaps Oral Delivery System Technology and Manufacturing with Genomma’s Strategic Marketing and Distribution Footprint “We’re excited to partner with Genomma, as this collaboration ...

Net Sales: Decreased by -5.7% in 2025 primarily reflecting a weak summer beverage season in Mexico, a softer consumption environment in the country and hyperinflationary effects. Net sales decreased ...

Genomma Lab Internacional SAB de CV engages in the development, manufacturing and marketing of pharmaceutical, beauty and personal care products. The company was founded by Rodrigo Alonso Herrera ...

Like-for-like ("LFL") sales: when adjusted into constant currency and excluding the hyperinflationary subsidiary, sales increased by 9.7% reflecting a double-digit increase in six out of nine core ...

BARRANQUILLA, Colombia & MEXICO CITY & MIAMI--(BUSINESS WIRE)--Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated international healthcare and pharmaceutical services company, and Genomma ...